BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17331163)

  • 1. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
    Matsuyama T; Uemura M; Ishikawa M; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Takimura C; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S27-35. PubMed ID: 17331163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
    Uemura M; Matsuyama T; Ishikawa M; Fujimoto M; Kojima H; Sakurai S; Ishii S; Toyohara M; Yamazaki M; Yoshiji H; Yamao J; Matsumoto M; Ishizashi H; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):264S-71S. PubMed ID: 16385234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia.
    Ishikawa M; Uemura M; Matsuyama T; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Tsujimoto T; Takimura C; Fujimura Y; Fukui H
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S25-33. PubMed ID: 19094193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of ADAMTS13 in the progression of alcoholic hepatitis.
    Uemura M; Fujimura Y; Matsuyama T; Matsumoto M; Ishikawa M; Ishizashi H; Kato S; Tsujimoto T; Fujimoto M; Yoshiji H; Morioka C; Fukui H
    Curr Drug Abuse Rev; 2008 Jun; 1(2):188-96. PubMed ID: 19630717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis.
    Morioka C; Uemura M; Matsuyama T; Matsumoto M; Kato S; Ishikawa M; Ishizashi H; Fujimoto M; Sawai M; Yoshida M; Mitoro A; Yamao J; Tsujimoto T; Yoshiji H; Urizono Y; Hata M; Nishino K; Okuchi K; Fujimura Y; Fukui H
    Scand J Gastroenterol; 2008; 43(11):1387-96. PubMed ID: 18609162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases.
    Ko S; Okano E; Kanehiro H; Matsumoto M; Ishizashi H; Uemura M; Fujimura Y; Tanaka K; Nakajima Y
    Liver Transpl; 2006 May; 12(5):859-69. PubMed ID: 16528712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
    Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
    Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis.
    Uemura M; Fujimura Y; Matsumoto M; Ishizashi H; Kato S; Matsuyama T; Isonishi A; Ishikawa M; Yagita M; Morioka C; Yoshiji H; Tsujimoto T; Kurumatani N; Fukui H
    Thromb Haemost; 2008 Jun; 99(6):1019-29. PubMed ID: 18521503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cleavage of von Willebrand factor by ADAMTS13 may contribute strongly to acquired von Willebrand syndrome development in patients with essential thrombocythemia.
    Kubo M; Sakai K; Hayakawa M; Kashiwagi H; Yagi H; Seki Y; Hasegawa A; Tanaka H; Amano I; Tomiyama Y; Matsumoto M
    J Thromb Haemost; 2022 Jul; 20(7):1589-1598. PubMed ID: 35352474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure.
    Takaya H; Yoshiji H; Kawaratani H; Sakai K; Matsumoto M; Fujimura Y; Fukui H
    Biomed Rep; 2017 Sep; 7(3):277-285. PubMed ID: 28894574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pivotal role of ADAMTS13 function in liver diseases.
    Uemura M; Fujimura Y; Ko S; Matsumoto M; Nakajima Y; Fukui H
    Int J Hematol; 2010 Jan; 91(1):20-9. PubMed ID: 20054668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability.
    Takaya H; Namisaki T; Asada S; Iwai S; Kubo T; Suzuki J; Enomoto M; Tsuji Y; Fujinaga Y; Nishimura N; Sawada Y; Kaji K; Kawaratani H; Moriya K; Akahane T; Matsumoto M; Yoshiji H
    J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group.
    Fujimoto M; Uemura M; Kojima H; Ishii Y; Ann T; Sakurai S; Okuda K; Noguchi R; Adachi S; Kitano H; Hoppo K; Higashino T; Takaya A; Fukui H
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):33S-38S. PubMed ID: 10235276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.
    Fukushima H; Nishio K; Asai H; Watanabe T; Seki T; Matsui H; Sugimoto M; Matsumoto M; Fujimura Y; Okuchi K
    Shock; 2013 May; 39(5):409-14. PubMed ID: 23481506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome.
    Hugenholtz GC; Adelmeijer J; Meijers JC; Porte RJ; Stravitz RT; Lisman T
    Hepatology; 2013 Aug; 58(2):752-61. PubMed ID: 23468040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
    Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
    Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
    Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
    Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the ADAMTS13-VWF axis in acute Kawasaki disease and effects of intravenous immunoglobulin.
    Tsujii N; Nogami K; Matsumoto M; Yoshizawa H; Takase T; Tanaka I; Sakai T; Fukuda K; Hayakawa M; Sakai K; Isonishi A; Matsuura K; Fujimura Y; Shima M
    Thromb Res; 2019 Jul; 179():1-10. PubMed ID: 31055186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.